Skip to main content
. 2017 Aug 2;12(8):e0182291. doi: 10.1371/journal.pone.0182291

Fig 4. ZO-1 expression was unchanged following treatment with TSA and iHDAC6.

Fig 4

(A) Immunocytochemical staining for ZO-1, LSR, TRIC, and Ac-tubulin in differentiated cochlear cells after TSA and iHDAC6 treatment. Scale bar: 20 μm. (B) Double-immunocytochemistry for ZO-1 and LSR in differentiated hair cells after TSA. Scale bar: 20 μm. (C) Western blotting for ZO-1 after treatment with 0.1 or 1 μM TSA and 0.1 or 1 μM iHDAC6.